CHANTALE BERNATCHEZ to Soft Tissue Neoplasms
This is a "connection" page, showing publications CHANTALE BERNATCHEZ has written about Soft Tissue Neoplasms.
Connection Strength
0.128
-
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial. Lancet Oncol. 2022 09; 23(9):1156-1166.
Score: 0.128
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.